Available studies (114 found)

Filter citations (author, year, title, ID)
Data type for full-text extraction
Short citationFull citationBioassayEpidemiologyEpi. meta-analysisIn vitroEcology
Saurel-Cubizolles, 1993 Saurel-Cubizolles MJ, Job-Spira N, and Estryn-Behar M. Ectopic pregnancy and occupational exposure to antineoplastic drugs. Lancet 1993; 341 (8854):1169-71. PubMed
Schaumburg 1989 Schaumburg I and Olsen J. Time to pregnancy among Danish pharmacy assistants. Scand J Work Environ Health 1989; 15 (3):222-6. PubMed
Schaumburg 1990a Schaumburg I and Olsen J. Congenital malformations and death among the offspring of Danish pharmacy assistants. Am. J. Ind. Med. 1990; 18 (5):555-64. PubMed
Schaumburg 1990b Schaumburg I and Olsen J. Risk of spontaneous abortion among Danish pharmacy assistants. Scand J Work Environ Health 1990; 16 (3):169-74. PubMed
Schaumburg 1991 Schaumburg I and Olsen J. Birth weight and gestational age among children of Danish pharmacy assistants. J Epidemiol Community Health 1991; 45 (1):49-51. PubMed
Selevan, 1985 Selevan SG et al. A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N. Engl. J. Med. 1985; 313 (19):1173-8. PubMed
Sessink, 1994a Sessink PJ, Cerna M, Rossner P, Pastorkova A, Bavarova H, Frankova K, Anzion RB, and Bos RP. 1994. Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents. Mutation research 309(2): 193-199. PubMed
Sessink, 1997a Sessink PJ, Verplanke AJ, Herber RF, and Bos RP. 1997. Occupational exposure to antineoplastic agents and parameters for renal dysfunction. International archives of occupational and environmental health 69(3): 215-218. PubMed
Shahrasbi, 2014 Shahrasbi AA, Afshar M, Shokraneh F, Monji F, Noroozi M, Ebrahimi-Khojin M, Madani SF, Ahadi-Barzoki M, and Rajabi M. 2014. Risks to health professionals from hazardous drugs in Iran: A pilot study of understanding of healthcare team to occupational exposure to cytotoxics. EXCLI Journal 13: 491-501. PubMed
Shortridge, 1995 Shortridge LA et al. Menstrual cycles in nurses handling antineoplastic drugs. Cancer Nurs 1995; 18 (6):439-44. PubMed
Skov, 1992 Skov T, Maarup B, Olsen J, Rorth M, Winthereik H, and Lynge E. 1992. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. British journal of industrial medicine 49(12): 855-861. PubMed
Sorsa, 1988 Sorsa M, Pyy L, Salomaa S, Nylund L, and Yager JW. 1988. Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals. Mutation research 204(3): 465-479. PubMed
Spatari, 2005 Spatari G, Fenga C, Minciullo PL, Di Pasquale G, Cacciola A, Ventura-Spagnolo E, and Gangemi S. 2005. Modification of interleukin-15 serum levels in workers exposed to chemotherapeutic agents. Mediators of inflammation 2005(1): 60-62. PubMed
Stücker, 1986 Stücker I, Hirsch A, Doloy T, Bastie-Sigeac I, and Hemon D. 1986. Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs. International archives of occupational and environmental health 57(3): 195-205. PubMed
Stücker, 1990 Stücker I et al. Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health 1990; 16 (2):102-7. PubMed
Stücker, 1993 Stücker I, Mandereau L, and Hémon D. Relationship between birthweight and occupational exposure to cytostatic drugs during or before pregnancy. Scand J Work Environ Health 1993; 19 (3):148-53. PubMed
Taskinen 1986 Taskinen H, Lindbohm ML, and Hemminki K. Spontaneous abortions among women working in the pharmaceutical industry. Br J Ind Med 1986; 43 (3):199-205. PubMed
Taskinen, 1994 Taskinen H, Kyyronen P, Hemminki K, Hoikkala M, Lajunen K, Lindbohm ML. 1994. Laboratory Work and Pregnancy Outcome. Journal of Occupational and Environmental Medicine 36(3): 311-319.
Testa, 2007 Testa A, Giachelia M, Palma S, Appolloni M, Padua L, Tranfo G, Spagnoli M, Tirindelli D, and Cozzi R. 2007. Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicology and applied pharmacology 223(1): 46-55. PubMed
Thiringer, 1991 Thiringer G, Granung G, Holmen A, Hogstedt B, Jarvholm B, Jonsson D, Persson L, Wahlstrom J, and Westin J. 1991. Comparison of methods for the biomonitoring of nurses handling antitumor drugs. Scandinavian journal of work, environment & health 17(2): 133-138. PubMed
Thulin, 1995 Thulin H, Sundberg E, Hansson K, Cole J, and Hartley-Asp B. 1995. Occupational exposure to nor-nitrogen mustard: chemical and biological monitoring. Toxicology and industrial health 11(1): 89-97. PubMed
Tigha Bouaziz 2016 Tigha Bouaziz N, Tourab D, Nezzal AM. 2016. Study of cardiovascular morbidity in nurses exposed to cytostatic drugs: Multivaried approach analysis. Annales de Cardiologie et d'Angeiologie 65(3): 179-184.
Undeger, 1999 Undeger U, Basaran N, Kars A, and Guc D. 1999. Assessment of DNA damage in nurses handling antineoplastic drugs by the alkaline COMET assay. Mutation research 439(2): 277-285. PubMed
Ursini, 2006 Ursini CL, Cavallo D, Colombi A, Giglio M, Marinaccio A, and Iavicoli S. 2006. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs. International archives of occupational and environmental health 80(2): 134-140. PubMed
Valanis, 1987 Valanis BG, Hertzberg V, and Shortridge L. 1987. Antineoplastic drugs. Handle with care. AAOHN journal : official journal of the American Association of Occupational Health Nurses 35(11): 487-492. PubMed

Showing studies 76-100 of 114